Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |